These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 33042132)

  • 21. TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells.
    Tawfik D; Groth C; Gundlach JP; Peipp M; Kabelitz D; Becker T; Oberg HH; Trauzold A; Wesch D
    Front Immunol; 2019; 10():2044. PubMed ID: 31555275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diminished cytolytic activity of γδ T cells with reduced DNAM-1 expression in neuroblastoma patients.
    Wang X; Mou W; Han W; Xi Y; Chen X; Zhang H; Qin H; Wang H; Ma X; Gui J
    Clin Immunol; 2019 Jun; 203():63-71. PubMed ID: 30999035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory Interactions Between Neutrophils, Tumor Cells and T Cells.
    Oberg HH; Wesch D; Kalyan S; Kabelitz D
    Front Immunol; 2019; 10():1690. PubMed ID: 31379875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity.
    Chitadze G; Oberg HH; Wesch D; Kabelitz D
    Trends Immunol; 2017 Sep; 38(9):668-678. PubMed ID: 28709825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. γδ T-cell Receptors Derived from Breast Cancer-Infiltrating T Lymphocytes Mediate Antitumor Reactivity.
    Janssen A; Villacorta Hidalgo J; Beringer DX; van Dooremalen S; Fernando F; van Diest E; Terrizi AR; Bronsert P; Kock S; Schmitt-Gräff A; Werner M; Heise K; Follo M; Straetemans T; Sebestyen Z; Chudakov DM; Kasatskaya SA; Frenkel FE; Ravens S; Spierings E; Prinz I; Küppers R; Malkovsky M; Fisch P; Kuball J
    Cancer Immunol Res; 2020 Apr; 8(4):530-543. PubMed ID: 32019779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. γδ T-cells in human malignancies: insights from single-cell studies and analytical considerations.
    Ng JWK; Cheung AMS
    Front Immunol; 2024; 15():1438962. PubMed ID: 39281674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adoptive immunotherapy of lung cancer with immobilized anti-TCRgammadelta antibody-expanded human gammadelta T-cells in peripheral blood.
    Kang N; Zhou J; Zhang T; Wang L; Lu F; Cui Y; Cui L; He W
    Cancer Biol Ther; 2009 Aug; 8(16):1540-9. PubMed ID: 19471115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Function of γδ T cells in tumor immunology and their application to cancer therapy.
    Park JH; Lee HK
    Exp Mol Med; 2021 Mar; 53(3):318-327. PubMed ID: 33707742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gamma-delta (γδ) T cells: friend or foe in cancer development?
    Zhao Y; Niu C; Cui J
    J Transl Med; 2018 Jan; 16(1):3. PubMed ID: 29316940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. γδ T cells and the PD-1/PD-L1 axis: a love-hate relationship in the tumor microenvironment.
    Liu J; Wu M; Yang Y; Wang Z; He S; Tian X; Wang H
    J Transl Med; 2024 Jun; 22(1):553. PubMed ID: 38858763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential of gamma/delta T cells for solid tumor immunotherapy.
    Zhu D; Ren X; Xie W; Chen J; Liang S; Jiang M; Wang J; Zheng Z
    Front Immunol; 2024; 15():1466266. PubMed ID: 39253082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between γδ T cells and neutrophils in cancer: knowns and unknowns.
    Hao J; Granot Z
    J Leukoc Biol; 2024 May; 115(6):993-995. PubMed ID: 38498617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
    Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
    Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy with γδ T-cells: the future is there.
    Kabelitz D; Yin Z
    Immunotherapy; 2024; 16(11):705-708. PubMed ID: 38940301
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of γδ T Cells in Cancer Progression and Therapy.
    Padmaraju V; Sankla Y; Malla RR
    Crit Rev Oncog; 2023; 28(4):59-70. PubMed ID: 38050982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adoptive immunotherapy of cancer using ex vivo expanded human gammadelta T cells: A new approach.
    Dokouhaki P; Han M; Joe B; Li M; Johnston MR; Tsao MS; Zhang L
    Cancer Lett; 2010 Nov; 297(1):126-36. PubMed ID: 20537791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deciphering human γδ T cell response in cancer: Lessons from tumor-infiltrating γδ T cells.
    Lo Presti E; Dieli F; Fourniè JJ; Meraviglia S
    Immunol Rev; 2020 Nov; 298(1):153-164. PubMed ID: 32691450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid.
    Fiore F; Castella B; Nuschak B; Bertieri R; Mariani S; Bruno B; Pantaleoni F; Foglietta M; Boccadoro M; Massaia M
    Blood; 2007 Aug; 110(3):921-7. PubMed ID: 17403919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human gammadelta-T cells in adoptive immunotherapy of malignant and infectious diseases.
    Lopez RD
    Immunol Res; 2002; 26(1-3):207-21. PubMed ID: 12403359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The capability of heterogeneous γδ T cells in cancer treatment.
    Yan W; Dunmall LSC; Lemoine NR; Wang Y; Wang Y; Wang P
    Front Immunol; 2023; 14():1285801. PubMed ID: 38077392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.